Understanding Labs - PowerPoint PPT Presentation

1 / 20
About This Presentation
Title:

Understanding Labs

Description:

Guidelines Exposed Pediatric. HIV exposed children. Labs: Medication. Birth ... Guidelines HIV Infected Ped. HIV Infected children: Frequency: Labs Medications ... – PowerPoint PPT presentation

Number of Views:65
Avg rating:3.0/5.0
Slides: 21
Provided by: ehar4
Category:

less

Transcript and Presenter's Notes

Title: Understanding Labs


1
Understanding Labs
  • Elizabeth Harkey, RN
  • University of Florida Jacksonville
  • Rainbow Center

2
Disclosure of Financial RelationshipsThis
speaker has the following significant financial
relationships with commercial entities to
disclose
  • Speakers Bureau - Gilead

This slide set has been peer-reviewed to ensure
that there are no conflicts of interest
represented in the presentation.
3
Objectives
  • This session will address the Standards of Care
    for
  • Newly HIV diagnosed patients
  • Experienced HIV infected patients.
  • Specific Laboratory/Diagnostic tests that might
    be needed due to HIV treatment
  • Virologic and Immunologic interpretations

4
(No Transcript)
5
Guidelines Exposed Pediatric
  • HIV exposed children
  • Labs Medication
  • Birth HIV DNA PCR 1 ZDV
  • 2 weeks Check ZDV dose
  • 6 weeks HIV DNA PCR 2 D/C ZDV
  • CBC/HH Start Septra
  • 2 month Post test F/U Septra start
  • 4 Month HIV DNA PCR 3 D/C Septra if DNA (-)
  • 15 Month Elisa Western Blot
  • 18 Month Elisa Western Blot

6
Guidelines HIV Infected Ped
  • HIV Infected children
  • Frequency Labs Medications
  • Q 3-4 months HIV RNA PCR (US) Doses checked
  • CD4/ CD8
  • Comprehensive chemistry
  • CBC w/ Diff
  • Q6- 12 months Lipids (Elevations with HAART/
    PIs)
  • Amylase
  • Lipase
  • Q12 months PPD or TB evaluation if HX of () PPD

7
Guidelines Adult/ Adolescent
  • Time point Labs
  • Initial HIV RNA PCR
  • CD4/CD8
  • Toxo IGG
  • CMV IGG
  • Hepatitis A total antibody
  • Hepatitis B Surface Antibody ( if immune)
  • Hepatitis B Surf Antigen ( with active
    infection)
  • Hepatitis B Core Antibody ( with past/
    present infec)
  • Hepatitis C Antibody
  • RPR (for syphilis)
  • Lipids (fasting if possible)
  • UA
  • Elisa Western Blot if not available
  • Genotype

8
Guidelines Adult/ Adolescent
  • Time point Labs
  • Q 3-4 months HIV RNA PCR (US)
  • (US if Viral Load is lt 5,000)
  • CD4/CD8
  • Comprehensive Chemistry
  • CBC with Differential

9
Guidelines Adult/ Adolescent
  • Time point Labs
  • Q 6-12 months
  • Lipids (fasting)
  • PPD
  • RPR (previously positive or sex active)
  • (females) PAPS w/ HPV, Gonorrhea Chlamydia
  • (males) Gonorrhea and Chlamydia

10
Specialty Tests
  • Genotype
  • HIV newly diagnosed
  • Before Beginning HAART
  • Increase in Viral Load (HIV RNA PCR) greater than
    1 log
  • 2 weeks after HAART w/o decrease Viral load
  • 4-6 months of being on HAART w/o Viral load being
    lt400 or lt50
  • Before discontinuing HAART

11
HIV Specific Abnormals
  • HIV RNA PRC gt1000 (on HAART)
  • Consider changing HAART
  • Genotype
  • Adherence re-enforcement

12
HIV Specific Abnormals
  • CD4 lt200 or lt15
  • Consider HAART
  • PCP prophylaxis (Bactrim/Septra every M, T, W)
  • Mepron, Dapsone (daily) Pentamadine (monthly)
  • CD4 lt100
  • Toxo prophylaxis (Bactrim, Septra, (M, T, W),
  • Dapsone (daily)
  • Toxo education areas to avoid (soil, cat feces)
  • CD4 lt 50
  • MAC prophylaxis (Zithromax weekly)
  • CMV retinitis (narrowing of peripheral vision)
  • Refer to ophthalmology for evaluation.

13
Other Abnormals
  • Hepatitis C Antibody ()
  • Hepatitis C RNA PCR
  • Hepatitis C Genotype
  • Hepatitis B Surface antigen () w/ Hepatitis B
    RNA PCR
  • Hepatitis B Core () History of Infection
  • Hepatitis Be Antigen ()
  • Increased risk of transmission

14
Other Abnormals
  • Toxoplasmosis ()
  • Assess CD4 count and
  • Treatment vs prophylaxis
  • CMV ()
  • Assess CD4 count and
  • Treatment vs prophylaxis

15
Other Abnormals
  • Lipid profile elevations
  • HAART involvement (Protease inhibitors, Sustiva,
    Zerit)
  • Genetic
  • Nutrition
  • Hemoglobin lt9.0 (symptomatic)
  • Medication side effects (ZDV, Videx)
  • Chronic Disease
  • Nutrition consult
  • Possibly start ferensol
  • Procrit

16
Other Abnormals
  • Absolute Neutrophil count (ANC) lt 1000
  • Medication side effect (Septra, ZDV)
  • Chronic Disease
  • Switch to Dapsone (if not G6PD deficient)
  • Switch to Mepron (if G6PD deficient)
  • ANC calculation
  • White blood cells x Granulocytes x 10
    Absolute Neutrophil count.
  • (Granulocytes Segs Bands Neutrophils)

17
Application
18
Application
19
(No Transcript)
20
References
  • Florida AIDS Education Training Center
    http//www.faetc.org/guide/index.asp
  • AIDS. ORG Laboratory results http//www.aids.org/F
    actsheets/120-Laboratory-Tests.html
  • AIDS Info HIV Medical Practice Guidelines
    http//www.aidsinfo.nih.gov/Guidelines/Default.asp
    x?MenuItemGuidelines
Write a Comment
User Comments (0)
About PowerShow.com